Abstract
Abstract
Background
Childhood-onset systemic lupus erythematosus (c-SLE) is a multifaceted autoimmune disorder predominantly affecting the musculoskeletal (MSK) system. This investigation delineated the spectrum and sequelae of MSK involvement in c-SLE patients.
Methods
This retrospective analysis included SLE patients aged ≤ 18 years treated at a tertiary center between 2009 and 2019. Data were extracted from electronic health records.
Results
The cohort comprised 321 SLE patients (mean age 13.2 ± 2.5 years, 91.3% female). MSK manifestations were observed in 134 (41.7%) individuals, with joint pain universally present, followed by joint swelling in 32.1% and morning stiffness in 9.7%. Arthritis was documented in 52 (38.8%) patients, whereas 82 (61.2%) had arthralgia. Symmetrical joint involvement was observed in 96 (71.7%) subjects. The knees, wrists, and fingers were most commonly affected, with incidences of 43.3%, 40.3%, and 33.6%, respectively. Neither erosive arthritis nor Jaccoud’s arthropathy was detected. MSK symptoms were significantly correlated with older age at diagnosis, the presence of non-scarring alopecia, neuropsychiatric manifestations, and elevated SLE disease activity index scores at diagnosis. Over a median follow-up of 53.6 months (IQR 26.1–84.6), five patients developed septic arthritis or osteomyelitis, and avascular necrosis was identified in 16 (4.9%) patients.
Conclusions
Nearly half of c-SLE patients demonstrated MSK manifestations, chiefly characterized by symmetrical involvement of both large and small joints without evidence of erosive arthritis or Jaccoud’s arthropathy. Avascular necrosis is a critical concern and warrants close monitoring.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus. 2004;13:851–3.
2. Ceccarelli F, Govoni M, Piga M, Cassone G, Cantatore FP, Olivieri G, Arthritis in Systemic Lupus Erythematosus: From, et al. International GISEA/OEG Symposium. J Clin Med. 2022;2022:11.
3. Shumilova A, Vital EM. Musculoskeletal manifestations of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2023;37(4):101859.
4. Bello N, Birt JA, Workman J, Zhou X, Ross-Terres JA, Petri M. Treatment patterns and clinical characteristics of patients with systemic lupus erythematosus and musculoskeletal symptoms: A retrospective, observational study. Adv Ther. 2022;39(7):3131–45.
5. Cornet A, Andersen J, Myllys K, Edwards A, Arnaud L, Living with systemic lupus erythematosus in,. a European patient survey. Lupus Sci Med. 2020;2021:8.